JP2002506072A5 - - Google Patents

Download PDF

Info

Publication number
JP2002506072A5
JP2002506072A5 JP2000535645A JP2000535645A JP2002506072A5 JP 2002506072 A5 JP2002506072 A5 JP 2002506072A5 JP 2000535645 A JP2000535645 A JP 2000535645A JP 2000535645 A JP2000535645 A JP 2000535645A JP 2002506072 A5 JP2002506072 A5 JP 2002506072A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
alkyloxy
carboxy
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000535645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1999/000121 external-priority patent/WO1999046267A1/en
Publication of JP2002506072A publication Critical patent/JP2002506072A/ja
Publication of JP2002506072A5 publication Critical patent/JP2002506072A5/ja
Withdrawn legal-status Critical Current

Links

JP2000535645A 1998-03-12 1999-03-11 プロテインチロシンホスファターゼ(PTPase)のモジュレーター Withdrawn JP2002506072A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DK0344/98 1998-03-12
DK34498 1998-03-12
DK0480/98 1998-04-03
DK48098 1998-04-03
DKPA199800938 1998-07-15
DK199800938 1998-07-15
DKPA199801385 1998-10-28
DK199801385 1998-10-28
DKPA199801612 1998-12-07
DK199801612 1998-12-07
PCT/DK1999/000121 WO1999046267A1 (en) 1998-03-12 1999-03-11 Modulators of protein tyrosine phosphatases (ptpases)

Publications (2)

Publication Number Publication Date
JP2002506072A JP2002506072A (ja) 2002-02-26
JP2002506072A5 true JP2002506072A5 (enExample) 2006-04-27

Family

ID=27512769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000535645A Withdrawn JP2002506072A (ja) 1998-03-12 1999-03-11 プロテインチロシンホスファターゼ(PTPase)のモジュレーター

Country Status (13)

Country Link
EP (1) EP1080095B1 (enExample)
JP (1) JP2002506072A (enExample)
KR (1) KR20010041814A (enExample)
CN (1) CN1300291A (enExample)
AT (1) ATE308546T1 (enExample)
AU (1) AU2713599A (enExample)
BR (1) BR9908726A (enExample)
CA (1) CA2323493A1 (enExample)
DE (1) DE69928100D1 (enExample)
HU (1) HUP0104984A3 (enExample)
IL (1) IL138319A0 (enExample)
NO (1) NO20004527L (enExample)
PL (1) PL342816A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002049632A1 (en) 2000-12-18 2002-06-27 Institute Of Medicinal Molecular Design. Inc. Inhibitors against the production and release of inflammatory cytokines
EA009523B1 (ru) * 2002-06-05 2008-02-28 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Ингибиторы в отношении активации ар-1 и nfat
CA2488342A1 (en) * 2002-06-05 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Therapeutic drug for diabetes
US7626042B2 (en) 2002-06-06 2009-12-01 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
AU2003242103A1 (en) 2002-06-06 2003-12-22 Institute Of Medicinal Molecular Design, Inc Antiallergic agents
EP1753512B1 (en) * 2004-05-28 2008-07-09 Nycomed GmbH Tetrahydropyridothiophenes
DE602005007220D1 (de) * 2004-06-04 2008-07-10 Nycomed Gmbh Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
JP2008501768A (ja) * 2004-06-11 2008-01-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の化合物及びテトラヒドロピリドチオフェンの使用
CA2881078C (en) * 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
CA2596202A1 (en) * 2005-02-09 2006-08-17 Altana Pharma Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
JP2008530053A (ja) * 2005-02-11 2008-08-07 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン
EP1926737B1 (en) * 2005-09-15 2017-03-15 F. Hoffmann-La Roche AG 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
CN104193761B (zh) * 2009-12-04 2017-10-17 桑诺维恩药品公司 多环化合物及其使用方法
CN102382076B (zh) * 2010-09-03 2016-08-17 中国医学科学院药物研究所 芳酮和芳酰胺类化合物及其制法和药物用途
CN102838625B (zh) * 2011-06-22 2015-04-15 中国科学院上海药物研究所 四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
US9682967B2 (en) 2013-01-28 2017-06-20 H. Lundbeck A/S N-substituted-5-substituted phthalamic acids as sortilin inhibitors
CN104788424A (zh) * 2015-03-12 2015-07-22 佛山市赛维斯医药科技有限公司 含烟酸酰胺和哌啶结构的ptp1b抑制剂、制备方法及其用途
CN104725306A (zh) * 2015-03-12 2015-06-24 佛山市赛维斯医药科技有限公司 一类含烟酸酰胺结构的ptp1b抑制剂、制备方法及其用途
CN104725308A (zh) * 2015-03-12 2015-06-24 佛山市赛维斯医药科技有限公司 含烟酸酰胺结构的ptp1b抑制剂、制备方法及其用途
CN104788425A (zh) * 2015-03-12 2015-07-22 佛山市赛维斯医药科技有限公司 一类含烟酸酰胺和哌啶结构ptp1b抑制剂、制备方法及其用途
CN104829629B (zh) * 2015-03-26 2017-03-15 天津药物研究院有限公司 含磺酰胺基的四氢噻吩并[2,3‑c]吡啶衍生物、其制备方法和用途
BR112019001407A2 (pt) 2016-07-29 2019-07-09 Sunovion Pharmaceuticals Inc. compostos e composições e usos dos mesmos
SG10202100724UA (en) 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
EP3582815A1 (en) 2017-02-16 2019-12-25 Sunovion Pharmaceuticals Inc. Methods of treating schizophrenia
MX2020000523A (es) 2017-08-02 2020-08-20 Sunovion Pharmaceuticals Inc Compuestos de isocromano y usos de los mismos.
SG11202007823PA (en) 2018-02-16 2020-09-29 Sunovion Pharmaceuticals Inc Salts, crystal forms, and production methods thereof
JP7703449B2 (ja) 2019-03-14 2025-07-07 スミトモ・ファーマ・アメリカ・インコーポレイテッド イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物
US12410191B2 (en) 2019-05-21 2025-09-09 Zhejiang Hisun Pharmaceutical Co., Ltd. Macrolide derivatives, preparation method and application thereof
KR20230003503A (ko) 2020-04-14 2023-01-06 선오비온 파마슈티컬스 인코포레이티드 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민
CN118290333A (zh) * 2020-04-14 2024-07-05 普渡研究基金会 新型淋巴特异性酪氨酸磷酸酶(lyp)抑制剂

Similar Documents

Publication Publication Date Title
ES2645859T3 (es) Derivados de tienopiridina como inhibidores de MEK
ES2255260T3 (es) Nuevos compuestos ciclicos sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2587013T3 (es) Derivados de ciclohexano espirocíclicos
ES2294047T3 (es) Un compuesto de ciclopenta (d) pirazolo(1,5-a) pirimidina como antagonista del receptor de crf.
WO2005023818A3 (en) Heterobicyclic compounds as pharmaceutically active agents
BRPI0714041A2 (pt) derivados de heteroaril substituìdos
ES2324788T3 (es) Derivados de ciclohexano espirociclicos.
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
CA2521732A1 (en) Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
EP1202964B1 (en) Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
AR030306A1 (es) Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento
GB0100621D0 (en) Chemical compounds VI
CO5080780A1 (es) Derivado de amida y antagonista de nociceptina
SI9200105B (en) Imidazo(2,1-b)(3)benzazepine derivatives, compositions and method of use
ES2535490T3 (es) Preparación de moduladores de receptores 5-HT
HUP0104984A2 (hu) Fehérje-tirozinfoszfatázokat (PTPázokat) moduláló vegyületek és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0100488A2 (hu) Tieno-pirimidinek, eljárás az előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
WO2003074531A1 (en) Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
EP1657242A4 (en) imidazopyridine
AU743230B2 (en) Condensed thienopyrimidines with phosphodiesterase-V inhibiting action
ES2309398T3 (es) Derivados 3,4-dihidro-tieno (2,3-d)pirimidin-4-ona-3-sustituidos, produccion y sus usos.
RU96111027A (ru) Трициклические 5,6-дигидро-9h-пиразоло [3,4-c]-1,2,4-триазоло [4,3-a]пиридины
KR20020010719A (ko) 포스포디에스테라제 저해제로서의 티에노피리미딘
ES2498797T3 (es) Derivados de pirrolina contra la liberación en las células del factor de necrosis tumoral, sus métodos de preparación y sus usos
ES2304546T3 (es) Derivados de priridoindolona sustituidos en la posicion 3 con un fenilo, su preparacion y su aplicacion en terapeutica.